Accurate Education - Magnesium Formulations

Magnesium:

Magnesium Formulations

Treatment guidelines for the use of magnesium supplements can be complicated. Guidelines generally guide dosing in terms of elemental magnesium doses, whereas commercial formulations come in a variety of magnesium salts, each of which has a different percentage content of elemental magnesium. This can make dosing recommendations difficult to follow, especially since there are multiple magnesium salt formulations commonly available. Each of these magnesium formulations in turn have their own unique characteristics that affect the choice of formulations for treatment.

See:

Magnesium

Key to Links:

Grey text – handout
Red text – another page on this website
Blue text – Journal publication

Definitions and Terms Related to Pain

Magnesium formulations

Elemental Magnesium Content by Formulation

Formulation	Elemental Mg Content	Notes	References
Magnesium Oxide	~60%	Highest elemental content but lowest bioavailability	[1], [2]
Magnesium Glycinate (Bisglycinate)	~14%	Excellent absorption, well tolerated	[1], [3]
Magnesium L-Threonate	~8%	Unique CNS penetration	[4], [5]
Magnesium Malate	~15%	Highest AUC in bioavailability studies	[2], [6]
Magnesium Citrate	~16-17%	Good absorption, mild laxative effect	[7]

Magnesium Oxide Dosing Conversions

Condition	Elemental Mg Dose	Magnesium Oxide Salt Dose	Dosing Frequency	References
Migraine prevention	400-600 mg/day	~670-1,000 mg/day	Once daily or divided BID	[1], [2]
Migraine prevention (trial dose)	500 mg/day	~830 mg/day	BID (500 mg oxide BID)	[1], [3]
Pediatric migraine	9 mg/kg/day elemental	~15 mg/kg/day oxide	Divided TID with food	[4]
General supplementation	300-400 mg/day	~500-670 mg/day	Once daily or divided	[5], [6]

Despite containing the highest percentage of elemental magnesium (~60%), magnesium oxide demonstrates the lowest bioavailability compared to organic magnesium compounds in comparative studies.[2][13] One study found that magnesium oxide and citrate had the lowest bioavailability when compared to magnesium malate and acetyl taurate.[2] However, a short-term supplementation study paradoxically showed that magnesium oxide demonstrated superior bioavailability in terms of increasing ionized magnesium concentration compared to citrate and carbonate formulations.[14]

Magnesium Glycinate (Bisglycinate) Dosing Conversions

Condition	Elemental Mg Dose	Magnesium Glycinate Salt Dose	Dosing Frequency	References
Chronic pain (general)	300-400 mg/day	~2,100-2,850 mg/day	Divided BID or TID	[1], [2]
Neuropathic pain	400-500 mg/day	~2,850-3,570 mg/day	Divided BID or TID	[2], [3]
Sleep support/fibromyalgia	300-400 mg/day	~2,100-2,850 mg/day	Evening or bedtime dosing	[2], [4]
GI-sensitive patients	200-300 mg/day	~1,430-2,100 mg/day	Divided BID	[1], [5]

Magnesium glycinate is classified among the most effectively absorbed organic salts along with citrate, aspartate, gluconate, and lactate.[1] The glycine component provides additional calming effects, making this formulation particularly suitable for patients with sleep disturbance or anxiety comorbidities. In dose-dependent absorption studies, magnesium glycinate was administered at 45, 135, and 405 mg/70 kg elemental magnesium doses, demonstrating good tissue penetration.[3]

Magnesium L-Threonate Dosing Conversions

Condition	Elemental Mg Dose	Magnesium L-Threonate Salt Dose	Dosing Frequency	References
Cognitive function/memory	140-190 mg/day	1,500-2,000 mg/day	Divided BID or TID	[1], [2]
Neuropathic pain (CIPN)	~144 mg/day	~1,800 mg/day	Divided doses	[3]
Central sensitization	140-190 mg/day	1,500-2,000 mg/day	Divided BID or TID	[3], [4]
Sleep improvement	~96 mg/day	~1,000 mg/day	500 mg BID	[1]
Radicular pain	~145 mg/day (human equivalent)	~1,800 mg/day	Divided doses	[4]

The unique property of magnesium L-threonate is its ability to elevate cerebrospinal fluid magnesium levels, which other formulations—including intravenous magnesium sulfate—fail to accomplish.[17][15] Clinical trials used 2,000 mg/day of the L-threonate compound (providing ~144-190 mg elemental magnesium) and demonstrated significant improvements in cognitive function within 30 days.[4]

Magnesium Malate Dosing Conversions

Condition	Elemental Mg Dose	Magnesium Malate Salt Dose	Dosing Frequency	References
Fibromyalgia/fatigue	250-300 mg/day	~1,670-2,000 mg/day	Once daily or divided BID	[1], [2]
Chronic pain (general)	300-400 mg/day	~2,000-2,670 mg/day	Divided BID	[3], [4]
Sustained serum levels	400 mg/day	~2,670 mg/day	Once daily	[1]

Magnesium malate demonstrated the highest area under the curve (AUC) in pharmacokinetic studies, with serum levels remaining elevated for an extended period compared to other formulations.[2] The Scottsdale Magnesium Study used 500 mg dimagnesium malate (providing 250 mg elemental magnesium) in a timed-release formulation, demonstrating a 30% increase in RBC magnesium over 90 days with minimal GI symptoms.[18]

Practical Conversion Quick Reference

To achieve 400 mg elemental Mg	Salt weight needed	Typical capsule count*	References
Magnesium Oxide	~670 mg	1-2 capsules	[1], [2]
Magnesium Glycinate	~2,850 mg	6-8 capsules	[1], [3]
Magnesium L-Threonate	~5,000 mg	10+ capsules (not practical)	[4], [5]
Magnesium Malate	~2,670 mg	5-6 capsules	[2], [6]
Magnesium Citrate	~2,500 mg	5-6 capsules	[7]

Based on typical 400-500 mg capsule sizes

Important Clinical Notes

The maximum recommended dose from supplements is 350 mg/day of elemental magnesium according to the Institute of Medicine, though clinical trials have safely used higher doses (up to 600 mg/day) for migraine prevention.[8][9] Magnesium toxicity has been associated with doses greater than 5,000 mg/day of elemental magnesium, with symptoms including hypotension, ileus, muscle weakness, and lethargy that can progress to cardiac arrest—risk is increased with reduced renal function.[8]

For L-threonate specifically, the lower elemental magnesium content means patients may need additional magnesium from other sources if total body repletion is the goal alongside CNS effects. Some clinicians recommend combining L-threonate (for CNS benefits) with glycinate or malate (for peripheral repletion) in patients with both central sensitization and systemic magnesium deficiency.

References

Magnesium Disorders. Touyz RM, de Baaij JHF, Hoenderop JGJ. The New England Journal of Medicine. 2024;390(21):1998-2009. doi:10.1056/NEJMra1510603.
Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best?. Uysal N, Kizildag S, Yuce Z, et al. Biological Trace Element Research. 2019;187(1):128-136. doi:10.1007/s12011-018-1351-9.
Dose-Dependent Absorption Profile of Different Magnesium Compounds. Ates M, Kizildag S, Yuksel O, et al. Biological Trace Element Research. 2019;192(2):244-251. doi:10.1007/s12011-019-01663-0.
Short-Term Magnesium Therapy Alleviates Moderate Stress in Patients With Fibromyalgia: A Randomized Double-Blind Clinical Trial. Macian N, Dualé C, Voute M, et al. Nutrients. 2022;14(10):2088. doi:10.3390/nu14102088.
Magnesium for Skeletal Muscle Cramps. Garrison SR, Korownyk CS, Kolber MR, et al. The Cochrane Database of Systematic Reviews. 2020;9:CD009402. doi:10.1002/14651858.CD009402.pub3.
Evaluation of Di-Magnesium Malate, Used as a Novel Food Ingredient and as a Source of Magnesium in Foods for the General Population, Food Supplements, Total Diet Replacement for Weight Control and Food for Special Medical Purposes. Younes M, Aggett P, Aguilar F, et al. EFSA Journal. European Food Safety Authority. 2018;16(6):e05292. doi:10.2903/j.efsa.2018.5292.
Magnesium Citrate Malate as a Source of Magnesium Added for Nutritional Purposes to Food Supplements. Turck D, Castenmiller J, De Henauw S, et al. EFSA Journal. European Food Safety Authority. 2018;16(12):e05484. doi:10.2903/j.efsa.2018.5484.
Management of Headache (2023). Jane Abanes PhD DNP MSN/Ed PMHCNS PMHNP-BC RN, Natasha M. Antonovich PharmD BCPS, Andrew C. Buelt DO, et al. Department of Veterans Affairs.
Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review. von Luckner A, Riederer F. Headache. 2018;58(2):199-209. doi:10.1111/head.13217.
The Effects of Magnesium, L-Carnitine, and Concurrent Magnesium-L-Carnitine Supplementation in Migraine Prophylaxis. Tarighat Esfanjani A, Mahdavi R, Ebrahimi Mameghani M, et al. Biological Trace Element Research. 2012;150(1-3):42-8. doi:10.1007/s12011-012-9487-5.
Oral Magnesium Oxide Prophylaxis of Frequent Migrainous Headache in Children: A Randomized, Double-Blind, Placebo-Controlled Trial. Wang F, Van Den Eeden SK, Ackerson LM, et al. Headache. 2003;43(6):601-10. doi:10.1046/j.1526-4610.2003.03102.x.
Magnesium and Pain. Shin HJ, Na HS, Do SH. Nutrients. 2020;12(8):E2184. doi:10.3390/nu12082184.
Bioavailability of Magnesium Food Supplements: A Systematic Review. Pardo MR, Garicano Vilar E, San Mauro Martín I, Camina Martín MA. Nutrition (Burbank, Los Angeles County, Calif.). 2021;89:111294. doi:10.1016/j.nut.2021.111294.
Effects of Short-Term Magnesium Supplementation on Ionized, Total Magnesium and Other Relevant Electrolytes Levels. Ivanovic ND, Radosavljevic B, Zekovic M, et al. Biometals : An International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine. 2022;35(2):267-283. doi:10.1007/s10534-022-00363-y.
Efficacy and Safety of Magnesium for the Management of Chronic Pain in Adults: A Systematic Review. Park R, Ho AM, Pickering G, et al. Anesthesia and Analgesia. 2020;131(3):764-775. doi:10.1213/ANE.0000000000004673.
Magnesium for Pain Treatment in 2021? State of the Art. Morel V, Pickering ME, Goubayon J, et al. Nutrients. 2021;13(5):1397. doi:10.3390/nu13051397.
Regulation of Structural and Functional Synapse Density by L-Threonate Through Modulation of Intraneuronal Magnesium Concentration. Sun Q, Weinger JG, Mao F, Liu G. Neuropharmacology. 2016;108:426-39. doi:10.1016/j.neuropharm.2016.05.006.
Scottsdale Magnesium Study: Absorption, Cellular Uptake, and Clinical Effectiveness of a Timed-Release Magnesium Supplement in a Standard Adult Clinical Population. Weiss D, Brunk DK, Goodman DA. Journal of the American College of Nutrition. 2018 May-Jun;37(4):316-327. doi:10.1080/07315724.2017.1398686.

Emphasis on Education

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

For more information, please contact Accurate Clinic.

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.